DRKS00015307
Recruiting
Not Applicable
oninvasive detection of circulating tumor DNA for disease classification and monitoring in patients with brain tumors.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C71
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with suspected brain cancer or diagnosed with brain cancer
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
Recruiting
Not Applicable
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200
Recruiting
Not Applicable
Detection of circulating tumor-DNA as a 'liquid biopsy' in patients with Ewing Sarcoma and PNET: a pilot studyEwing-Sarcoma (C41.9)primitive neuroectodermal tumor (C71.9)C41.9C71.9Bone and articular cartilage, unspecifiedBrain, unspecifiedDRKS00009029niversitätsklinikum Freiburg30
Unknown
Not Applicable
Detection of circulating tumor DNA by droplet digital PCR in patients with unresectable or recurrent gastric cancergastric cancerJPRN-UMIN000026605Second Department of Surger, Wakayama medical university, School of Medicine20